Cargando…

Circulating cell-free DNA for cancer early detection

Effective screening modalities are currently available for only a small subset of cancers, and they generally have suboptimal performance with complicated procedures. Therefore, there is an urgent need to develop simple, accurate, and non-invasive methods for early detection of cancers. Genetic and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Qiang, Zeng, Qiang, Wang, Zhijie, Li, Chengcheng, Xu, Yu, Cui, Peng, Zhu, Xin, Lu, Huafei, Wang, Guoqiang, Cai, Shangli, Wang, Jie, Fan, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133648/ https://www.ncbi.nlm.nih.gov/pubmed/35647572 http://dx.doi.org/10.1016/j.xinn.2022.100259

Ejemplares similares

Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
por: Sui, Jinke, et al.
Publicado: (2021)

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study
por: Qiao, Guibin, et al.
Publicado: (2021)

Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC
por: Sun, Yiting, et al.
Publicado: (2021)

DNA Damage Response Gene-Based Subtypes Associated With Clinical Outcomes in Early-Stage Lung Adenocarcinoma
por: Zhao, Yang, et al.
Publicado: (2022)

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer
por: Li, Teng, et al.
Publicado: (2021)

IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers
por: Liu, Yutao, et al.
Publicado: (2023)

Co-occurring genomic alterations and immunotherapy efficacy in NSCLC
por: Zhang, Fan, et al.
Publicado: (2022)

Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials
por: Cai, Shangli, et al.
Publicado: (2015)

Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis
por: Xing, Puyuan, et al.
Publicado: (2019)

Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers
por: Hu, Shuo, et al.
Publicado: (2023)

EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma
por: Bai, Hua, et al.
Publicado: (2020)

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
por: Jaworski, Jedrzej J., et al.
Publicado: (2020)

Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
por: Cai, Jiabin, et al.
Publicado: (2019)

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer
por: Liang, Leilei, et al.
Publicado: (2022)

Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma
por: Mao, Guangxian, et al.
Publicado: (2023)

A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma
por: Xu, Jiachen, et al.
Publicado: (2023)

Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis
por: Wang, Xin, et al.
Publicado: (2018)

Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?
por: Yuan, Zuyang, et al.
Publicado: (2020)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes
por: Qiu, Zhiquan, et al.
Publicado: (2022)

Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy
por: Zhou, Yidong, et al.
Publicado: (2016)

Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer
por: Wang, Bi, et al.
Publicado: (2017)

The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis
por: Tan, Guoqiang, et al.
Publicado: (2018)

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA
por: Guler, Gulfem D., et al.
Publicado: (2020)

An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas
por: Cai, Jiajun, et al.
Publicado: (2021)

A prognostic 15-gene model based on differentially expressed genes among metabolic subtypes in diffuse large B-cell lymphoma
por: Hou, Jun, et al.
Publicado: (2023)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort study
por: Mo, Shaobo, et al.
Publicado: (2022)

Changes in circulating cell-free nuclear DNA and mitochondrial DNA of patients with adolescent idiopathic scoliosis
por: Li, Jiong, et al.
Publicado: (2019)

Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer
por: Huang, Chiang-Ching, et al.
Publicado: (2019)

Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection
por: Pantel, Klaus
Publicado: (2016)

Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
por: Uehiro, Natsue, et al.
Publicado: (2016)

Targeted Sequencing of Genomic Repeat Regions Detects Circulating Cell-free Echinococcus DNA
por: Wan, Zhengqing, et al.
Publicado: (2020)

Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation
por: Wang, Zhoufeng, et al.
Publicado: (2023)

Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer
por: Yang, Xue, et al.
Publicado: (2016)

Chiral Antioxidant-based Gold Nanoclusters Reprogram DNA Epigenetic Patterns
por: Ma, Yue, et al.
Publicado: (2016)

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma
por: Chen, Yongwei, et al.
Publicado: (2023)

Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer
por: Zhou, Yidong, et al.
Publicado: (2019)

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
por: Li, Wenshuai, et al.
Publicado: (2017)

The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
por: Basnet, Shiva, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_258stea59ejsa957m9vga3lvsu